Skip to main content
. 2020 Aug 4;10(5):452–465. doi: 10.1016/j.jpha.2020.07.009

Table 5.

InRAGER2 lead profiling screen assay results. Primary assays were performed at 10 μM InRAGER2 to determine the percent inhibition; secondary dose response determined IC50 and Ki.

Assay name %Inhibition at 10 μM Ki (μM) IC50 (μM)
5-HT2B receptor 95 0.13 0.26
Urotensin receptor 85 1.0 1.4
Translocator protein 18 kDa (TSPO) 81 0.44 0.48
Adenosine A3 receptor 75 0.83 1.4
Cyclooxygenase 1 72 n.d.a 12
a

n.d. = not determined.